IMEXF Company Profile and Key Details

The stock is currently trading near its 52-week low $0.00 and $0.01. With a market capitalization of about $1.08 thousand, Imagin Medical Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~1.65). Key stats such as the average daily volume over the past year has been around 27.72 thousand shares, in line with its 52-week average. Headquartered in Vancouver, BC, Imagin Medical Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO E. James Hutchens, the company employs approximately 10 people and listed since July 10, 2009. Imagin Medical Inc., a urologic oncology company, focuses on the research, development, and commercialization of medical devices in the bio-chemistry industry.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Valuation shows Imagin Medical Inc. trading at a premium to the broader market with a P/E of -0.0.

Our AI price prediction model suggests that Imagin Medical Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Imagin Medical Inc. trades at a P/E ratio of -0.0, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 The P/FCF stands at -0.0, also above market averages.